|  | |  |  | (R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide Basic information | 
 | Product Name: | (R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide |  | Synonyms: | (R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide;Y 33075;Y33075;Y 39983;Y 39983;Y39983;Benzamide, 4-[(1R)-1-aminoethyl]-N-1H-pyrrolo[2,3-b]pyridin-4-yl-;4-[(1R)-1-Aminoethyl]-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide;(R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide ISO 9001:2015 REACH;Y 33075,Y33075 |  | CAS: | 199433-58-4 |  | MF: | C16H16N4O |  | MW: | 280.32 |  | EINECS: |  |  | Product Categories: |  |  | Mol File: | 199433-58-4.mol |  | ![(R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide Structure](CAS2/GIF/199433-58-4.gif) | 
|  |  | (R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide Chemical Properties | 
 | Boiling point | 588.8±50.0 °C(Predicted) |  | density | 1.32 |  | storage temp. | Store at -20°C |  | solubility | DMSO : 50 mg/mL (178.37 mM; Need ultrasonic and warming)H2O : < 0.1 mg/mL (insoluble) |  | form | Powder |  | pka | 11.13±0.20(Predicted) | 
|  |  | (R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide Usage And Synthesis | 
 | Definition | ChEBI: 4-[(1R)-1-aminoethyl]-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide is a pyrrolopyridine. |  | Biological Activity | Y-33075 is a potent ROCK inhibitor derived from Y-27632, but more active with IC50 value of 3.6 nM. |  | in vitro |   Y-33075 (Y-39983) is a potent ROCK inhibitor, with an IC  50  of 3.6 nM. It also inhibits PKC and CaMKII more potently than Y-27632, and the IC  50  s of Y-27632 and Y-33075 for PKC are 9.0 μM and 0.42 μM, respectively, whereas the IC  50  s of Y-27632 and Y- 33075 for CaMKII are 26 μM and 0.81 μM, respectively. The IC  50  s of Y-27632 and Y-33075 for PKC are 82 and 117 times those for ROCK, respectively, whereas the IC  50  s of Y-27632 and Y-33075 for CaMKII is 236 and 225 times those for ROCK, respectively. Y-33075 (Y-39983, 10 μM) extends neurites in the retinal ganglion cells (RGCs) compared with those in RGCs treated without Y-39983. It (Y-39983, 1 μM) inhibits the contraction of rabbit ciliary artery segments evoked by histamine in Ca  2+  -free solutions. Y-33075 ( 10 μM) shows no effect on the [Ca  2+  ]i increase with the high-potassium (high-K) solution.       p> |  | target |  |   ROCK     3.6 nM (IC  50  )   |   PKC     420 nM (IC  50  )   |   CaMKII     810 nM (IC  50  )   |  | 
|  |  | (R)-4-(1-Aminoethyl)-N-1H-pyrrolo[2,3-b]pyridin-4-ylbenzamide Preparation Products And Raw materials | 
 |